Pharmafile Logo

Kraeber (UK) Ltd

The family owned business, Kraeber & Co GmbH, is an independent, technology based enterprise which was founded on the 1st January 1980 in Hamburg. Hanseatic tradition together with courageous entrepreneurship characterize our company. We are committed to open and global competition which we stand up with our service capabilities. Our emphasis is the development, production, marketing and sales of active pharmaceutical ingredients (APIs) of the highest purity. Kraeber has evolved into a niche marketer and supplier. By continously innovating productions, we became the quality market leader in Europe and in other parts of the world for many of our products.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

16 The Street, Saxon Street, Newmarket, Suffolk, CB8 9RU, United Kingdom
+44 (0)1638 731 297

 Latest Content from PMHub 

Transitioning to the “New Normal”: What This Means for Oncology Care

Videos and Podcasts | September 9, 2021 | Impetus Digital

Dr. Burt Zweigenhaft, Co-founder of the Association for Value-Based Cancer Care, shares his thoughts on the importance of patient-centricity in cancer care, current barriers to value-based care in the US...

DOVETAIL & IBD REGISTRY WIN AGILITY AND FLEXIBILITY AWARD AT COMMUNIQUÉ 2021

Press Releases | September 7, 2021 | Dovetail

The award was the first to be won in Communiqué’s new AGILITY AND FLEXIBILITY category.

Making Wearable Technology Scalable and Adoptable

Videos and Podcasts | September 2, 2021 | Impetus Digital

Ilaria Varoli, EVP of Myant Inc., explores Textile Computing™ for remote monitoring, health assessments, pediatric and maternal care, temperature regulation, monitoring of athlete performance, and much more.

Lucid Group celebrates a double win at Communiqué 2021

Lucid scooped a double win at this year’s Communiqué awards, the first face-to-face industry event since the start of the pandemic – making it an extra-special occasion for everyone attending....

Courageous Conversation ep.12: Not Going Back: How COVID Has Changed Clinical Trials

Videos and Podcasts | September 2, 2021 | Impetus Digital

Natalie Yeadon, CEO & Co-Founder at Impetus Digital, provides insight into how COVID has changed clinical trials.

Courageous Conversation ep.11: How to Inspire Creativity with Virtual Working Groups

Videos and Podcasts | September 2, 2021 | Impetus Digital

Natalie Yeadon, Co-Founder & CEO at Impetus Digital, provides insight on how to inspire creativity with virtual working groups.

News:

White Papers and Resources | September 1, 2021 | Inizio

Therapy Watch COVID-19 tracker

Events:

White Papers and Resources | September 1, 2021 | Inizio

Patient Centricity and Engagement Conference 2021

Parallel HCP-Patient Advisory Boards: A Customer Story

Learn how a Pharma team engaged both dermatologists and patients with psoriasis in two parallel virtual advisory boards.

Hepatitis (C)an’t wait: taking a de-centralized approach to cure the epidemic

Hepatitis C is a curable disease, so why are so many countries off track to achieve the World Health Organization elimination target? This World Hepatitis Day, we compare several countries’...